How to get vaccinated for COVID-19
Getting vaccinated is easy and safe. Spread the word and help your friends and family get vaccinated.
Last updated: May 13, 2022
Getting vaccinated is easy
You can register yourself or someone else, like a parent, grandparent or child. We will never ask you for your SIN, driver's licence number or banking and credit card details.
Once you've registered, you'll be able to book an appointment using your confirmation number. Booking an appointment online or by phone is easy, convenient and guarantees your vaccination at a community pharmacy or vaccination clinic near you.
If needed, you can easily reschedule your appointment online.
Fastest option: Online
To register online, you must provide:
- First and last name
- Date of birth
- Postal code
- Personal Health Number (PHN)
- An email address that gets checked regularly or a phone number that can receive text messages
Find your PHN on the back of your B.C. driver's licence, BC Services Card or CareCard.
Register online It takes 2 minutes
Other registration and booking options
If you don't have a Personal Health Number (PHN), you need to register by phone. A PHN will be created for you.
Call: 1-833-838-2323 | Translators are available
Seven days a week, 7 am to 7 pm (PDT)
Outside Canada and the USA: 1-604-681-4261
Telephone for the Deaf: Dial 711
Video Relay Services (VRS) provides sign language interpretation free for registered deaf, hard of hearing or speech-impaired people.
Everyone can get vaccinated, even if you don’t have a PHN or other documentation.
It doesn't matter if you are a Canadian citizen or not. Register even if you have already received dose 1 in another location. All of your information will be kept private and will never be shared with other agencies or parts of government.
Ages 12 to 17
Under the Infants Act, you can give consent as a mature minor to receive health care, like getting a vaccine. If you feel more comfortable getting vaccinated with a trusted adult, they can come with you to your vaccination. When you arrive at your appointment, you will complete a check-in process. It's also a good idea to bring one piece of child identification, for example:
- BC Services card
- B.C. driver's licence
- School ID card
- Birth certificate
- Bank card
Ages 5 to 11
The Pfizer and Moderna mRNA vaccines for children use a smaller dosage of the same vaccine used for youth and adults. Children need a smaller dose of the vaccine to get the same protection from COVID-19.
We recommend you review information on COVID-19 vaccine safety from HealthlinkBC before your appointment. You can expect to be at your appointment for 15 to 30 minutes.
Get ready for your appointment:
- You do not need to fast. Be sure to drink water
- Bring your booking confirmation and photo ID
- Wear a short-sleeved shirt and a mask. You will be provided a mask if you need one
- Arrive a few minutes before your scheduled appointment time
During the appointment
At the pharmacy or clinic you will:
- Check-in with your photo ID and booking confirmation. For modesty, you can ask for a private location to get your shot
- Get either the Pfizer or Moderna vaccine dose. A choice will not be offered
- Wait in an observation area after your shot for about 15 minutes
After your appointment, review COVID-19 Vaccination Aftercare (PDF, 953KB) from the BCCDC.
To get the most effective protection against serious cases of COVID-19, you need two doses of vaccine. You're not fully protected until you've had both doses.
Approximately 56 days after your first dose, you will get an invitation by text, email or phone call to book your second dose appointment. Like your first appointment, you'll select a location, date and time.
People with moderately to severely compromised immune systems will generally have lower antibody responses from two COVID-19 vaccine doses. Studies show that giving a third dose to complete the initial vaccine series can help these individuals create antibodies to protect them from COVID-19.
People who are moderately to severely immunocompromised and meet the criteria will receive a third dose of vaccine.
Have had a solid-organ transplant and are taking immunosuppressive therapy:
- Have had a solid organ transplant. May include a heart, lung, liver, kidney, pancreas or islet cells, bowel or combination organ transplant
Will have, are having, or are on active treatment for solid tumour or hematologic malignancies (like myeloma or leukemia):
- Will have, are having, or in the last 12 months have received systemic treatment for a haematological malignancy including anti-CD20 or other B-cell depleting therapies
- Will have, are having, or in the last 24 months have had a bone marrow, stem cell transplant or CAR-T or who are still taking immunosuppressive drugs
- Will have, are having, or in the last 6 months have received anti-cancer systemic therapy for solid tumours (including but not limited to cytotoxic chemotherapy; molecular targeted therapy; immunotherapy; monoclonal antibodies; bone modifying agents used in the setting of metastatic disease; high dose steroids e.g equivalent to > 20mg/day for more than 1 month but excluding patients only receiving hormonal or bone modifying therapy in the adjuvant setting)
- Are planned for radiation, are having or will have had radiation in the last 3 months
- Have a diagnosis of CLL/SLL, myeloma/plasmacytoma, or low grade lymphoma
Prior AIDS defining illness or prior CD4 count ≤ 200/mm3 or prior CD4 fraction ≤ 15% or any detectable plasma viral load since January 2021 or HIV infection and ≥ 65 years old or perinatally acquired HIV infection.
Are on active treatment with the following categories of immunosuppressive therapies:
- In the last 2 years, been treated with anti-CD20 agents or similar therapeutic agents: examples include rituximab, ocrelizumab, ofatumumab, obinutuzumab, ibritumomab, tositumomab
- In the last 2 years, been treated with B-cell depleting agents or similar therapeutic agents: examples include epratuzumab, MEDI-551, belimumab, BR3-Fc, AMG-623, atacicept, anti-BR3, alemtuzumab
- In the last 3 months, been treated with biologic agents that are significantly immunosuppresive: examples include abatacept, adalimumab, anakinra, anifrolumab, benralizumab, brodalumab, canakinumab, certolizumab, dupilumab, eculizumab, etanercept, golimumab, guselkumab, infliximab, interferon products (alpha, beta, and pegylated forms), ixekizumab, mepolizumab, natalizumab, omalizumab, ravulizumab, resilizumab, risankizumab, sarilumab, secukinumab, tocilizumab, ustekinumab, or vedolizumab
- In the last 3 months, been treated with oral immune-suppressing drugs: examples include azathioprine, baricitinib, cyclophosphamide, cyclosporine, leflunomide, dimethyl fumerate, everolimus, fingolimod, mycophenolate, siponimod, sirolimus, tacrolimus, tofacitinib, upadacitinib, methotrexate, dexamethasone, hydrocortisone, prednisone (adult dose or pediatric dose equivalent of ≥20 mg per day or ≥2mg/kg daily if bodyweight <10 kg), methylprednisolone, teriflunomide, or voclosporin
- In the last 3 months, been treated with steroids orally or by injection on an ongoing basis (>14 days) that would interfere with immune responses: examples include dexamethasone, hydrocortisone, methylprednisolone, or prednisone (adult dose or pediatric dose equivalent of ≥20 mg per day or ≥2mg/kg daily if bodyweight <10 kg)
- In the last 3 months, been treated with immune-suppressing infusions/injections: examples include cladribine, cyclophosphamide, glatiramer, methotrexate
- In the last 3 months, been treated with intermittent high dose steroids administered as immune suppression prior to intravenous enzyme replacement treatment
Have combined immune deficiencies affecting T-cells, immune dysregulation (particularly familial hemophagocytic lymphohistiocytosis) or those with type 1 interferon defects (caused by a genetic primary immunodeficiency disorder or secondary to anti-interferon autoantibodies).
Have a moderate to severe primary immunodeficiency which has been diagnosed by an adult or pediatric immunologist and requires ongoing immunoglobulin replacement therapy (IVIG or SCIG) or the primary immunodeficiency has a confirmed genetic cause (e.g. DiGeorge syndrome, Wiskott-Aldrich syndrome).
Are on dialysis and/or with severe kidney or renal disease:
- On dialysis (hemodialysis or peritoneal dialysis) or have stage 5 chronic kidney disease (eGFR <15ml/min or have glomerulonephritis and receiving steroid treatment
You will be contacted by the provincial Get Vaccinated system about how and when to book a third dose, about 4 weeks after you receive your second dose.
- If you've selected email or SMS communication, you'll be sent a link to book an appointment online
- If you've asked to be contacted by phone, a call centre agent will call you to book an appointment
If you believe you meet the criteria of people who are moderately to severely immunocompromised and haven't been contacted, get in touch with your health care provider.
Getting a non-mRNA vaccine for dose 1
Getting a non-mRNA for dose 2 or your booster
- Wait until you receive your dose 2 or booster booking invitation
- Call 1-833-838-2323 to be put on the non-mRNA waiting list
Even if you've already had COVID-19 and recovered, you should still get vaccinated.
If you were recently sick, you can get the vaccine once your symptoms have passed.
If you have an appointment but you still have symptoms, reschedule for when you will be fully recovered.